Literature DB >> 30095197

The role of the long non-coding RNA HOXA11-AS in promoting proliferation and metastasis of malignant tumors.

Shounan Lu1, Xingming Jiang1, Zhilei Su1, Zhankun Cui1, Wen Fu1, Sheng Tai1.   

Abstract

Long non-coding RNA (lncRNA) is one of the focuses and hotspots of biological research in recent years. At the same time, tumors have become the main disease that endangers human health. In recent years, a large number of researchers have explored the relationship between lncRNA and tumors. HOXA11-AS is one of these lncRNAs. The long non-coding RNA HOXA11 antisense RNA (HOXA11-AS) is a novel lncRNA recently discovered. It is found in a variety of tumors such as ovarian cancer, glioma, and gastric cancer (GC) and so on, and is defined as an oncogene. It promotes tumor proliferation and metastasis by interacting with proteins such as miRNA and EZH2. In this paper, we review the mechanism of interaction between HOXA11-AS and various tumors in recent years, and believe that it can be a potential tumor marker and therapeutic target in the future prevention and treatment of tumors.
© 2018 International Federation for Cell Biology.

Entities:  

Keywords:  HOXA11-AS; LncRNA; cancer; carcinogenesis

Mesh:

Substances:

Year:  2018        PMID: 30095197     DOI: 10.1002/cbin.11045

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  9 in total

1.  LncRNA HOXA11-AS regulates the proliferation and epithelial to mesenchymal transition of human skin cancer cells.

Authors:  Jigang Wang; Xiuli Li; Hui Li; Xin Li
Journal:  3 Biotech       Date:  2021-01-02       Impact factor: 2.406

2.  Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.

Authors:  Hua Cao; Xinsheng Han; Yonglin Jia; Baohua Zhang
Journal:  Aging (Albany NY)       Date:  2021-04-04       Impact factor: 5.682

3.  Long non‑coding RNA HOXA11‑AS accelerates cell proliferation and epithelial‑mesenchymal transition in hepatocellular carcinoma by modulating the miR‑506‑3p/Slug axis.

Authors:  Yinghui Liu; Wenzhao Yan; Dongfang Zhou; Guohua Jin; Xin Cheng
Journal:  Int J Mol Med       Date:  2020-08-28       Impact factor: 4.101

4.  LINC01094/miR-577 axis regulates the progression of ovarian cancer.

Authors:  Jing Xu; Ping Zhang; Huajun Sun; Yang Liu
Journal:  J Ovarian Res       Date:  2020-10-17       Impact factor: 4.234

Review 5.  Potential of long non-coding RNAs as a therapeutic target and molecular markers in glioblastoma pathogenesis.

Authors:  Rishabh Chaudhary
Journal:  Heliyon       Date:  2021-03-15

6.  A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels.

Authors:  Siyang Wen; Yilu Qin; Rui Wang; Liping Yang; Huan Zeng; Pengpeng Zhu; Qiao Li; Yuxiang Qiu; Shanchun Chen; Yongcan Liu; Yixuan Hou; Xi Tang; Manran Liu; Gang Tu
Journal:  Cell Death Dis       Date:  2021-05-01       Impact factor: 8.469

7.  An Axis between the Long Non-Coding RNA HOXA11-AS and NQOs Enhances Metastatic Ability in Oral Squamous Cell Carcinoma.

Authors:  Chie Nakashima; Rina Fujiwara-Tani; Shiori Mori; Shingo Kishi; Hitoshi Ohmori; Kiyomu Fujii; Takuya Mori; Yoshihiro Miyagawa; Kazuhiko Yamamoto; Tadaaki Kirita; Yi Luo; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2022-09-14       Impact factor: 6.208

Review 8.  LncRNA as a multifunctional regulator in cancer multi-drug resistance.

Authors:  Jiaying He; Shaomi Zhu; Xin Liang; Qinxiu Zhang; Xiaohong Luo; Chi Liu; Linjiang Song
Journal:  Mol Biol Rep       Date:  2021-07-31       Impact factor: 2.316

Review 9.  Recent advances in unraveling the molecular mechanisms and functions of HOXA11‑AS in human cancers and other diseases (Review).

Authors:  Cheng Wei; Liangjuan Zhao; Hao Liang; Yingwei Zhen; Lei Han
Journal:  Oncol Rep       Date:  2020-03-19       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.